NYSE:JNJ

The Science & Art of Goal Setting: Announcing Johnson & Johnson's New Climate Goals

by Paulette Frank, Worldwide Vice President, Environmental Health, Safety & Sustainability at Johnson & Johnson
Blog

I am so incredibly proud to have had the privilege to share Johnson & Johnson’s new climate goals during this Climate Week NYC 2020.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

The Next Phase of Our COVID-19 Vaccine Development

by Alex Gorsky Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Blog

It’s hard to believe that just six months have passed since our scientists identified Janssen’s lead COVID-19 vaccine candidate. We couldn’t have predicted all the changes that have happened since. Two things, however, have been constant: COVID-19 continues to be a devastating pandemic, and Johnson & Johnson has been working around the clock on a potential solution.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

Johnson & Johnson Consumer Health Commits $800 Million Through 2030 to Make Its Products More Sustainable for a Healthier Planet

Summary: 

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

Article

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

4 High-Tech Tools Johnson & Johnson Is Using to Get Products to You During the Pandemic

Article

When the COVID-19 pandemic first hit, everyday staples like toilet paper and paper towels were suddenly seemingly nowhere to be found. Over-the-counter products, like fever reducers and cough medicine, were in high demand—along with hand sanitizer, disinfectant sprays and cleaning wipes.

The Road to a Vaccine, Season 2, Ep. 6: Everything You Need to Know about COVID-19 Testing and Contact Tracing

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As we head into fall, how is COVID-19 testing going? Lisa Ling speaks to experts, including Ann Lee, co-founder, with actor Sean Penn, of the nonprofit CORE, to get the latest updates on testing efforts and contact tracing across America.

Our Integrated Approach to Health (of People and Our Planet)

by Thibaut Mongon, Executive Vice President and Worldwide Chairman of Consumer Health at Johnson & Johnson
Blog

Human health is complex.

Physical health is interdependent with the health of our communities and the planet. They can’t be teased apart from one another.

As part of the world’s largest healthcare company, Johnson & Johnson Consumer Health is uniquely positioned and has a responsibility to approach health (of people and our planet) in an integrated way. We can leverage our science, scale, and reach to improve the health of both people and the planet.

Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine

In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
Article

Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approvals of the first vaccines for COVID-19.

The Road to a Vaccine, Season 2, Ep. 5: What Have We Learned After Eight Months of COVID-19?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 5, Lisa Ling asks health experts for a pandemic status report, including the latest statistics on cases worldwide, the current thinking about coronavirus and its effects and what’s working to fight the disease—and what’s not.

Pages

Subscribe to NYSE:JNJ